Navigation Links
Cancer drugs in development nearly doubled since 1995

The number of drugs being developed for the treatment of cancer has nearly doubled during the past six years, according to a new survey of pharmaceutical companies. Currently, 170 pharmaceutical and biotechnology firms various Cancer Institutes are investigating 402 compounds for the treatment of various cancers, up from 215 in 1995. Many of the drugs are alternatives to standard radiation and chemotherapy. For lung cancer, the leading cause of cancer-related death in the United States, there are 68 drugs in the pipelines of various companies. Experimental drugs for the treatment of breast cancer total 59, while there are 55 for colon cancer, 52 for skin cancer and 52 for prostate cancer. Other cancers being targeted include solid tumors, sarcomas, pancreatic cancer, ovarian cancer, multiple myeloma, lymphoma, liver cancer, leukemia, kidney cancer, brain cancer, stomach cancer and bladder cancer. Of the drugs in development, 17 are waiting for Food and Drug Administration approval (FDA). Thanks in large part to medicines developed in the past decade, cancer deaths are on the decline. But cancer is still the second leading cause of American deaths by disease.
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
10. Cancer patients turning to Internet for information
11. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/25/2017)... ... ... Getting earned media coverage meaningful for Garden Media Group's clients is the ... Garden Media aims to provide material helpful to clients’ goals and bottom lines. By ... messages to gain coveted media placements, Garden Media wows clients year-round. , Here ...
(Date:3/24/2017)... ... 24, 2017 , ... Clean Earth, Inc., a leader in ... non-hazardous materials announced today the acquisition of privately owned AERC Recycling Solutions ... processing facilities and a vast array of additional technologies, services, and new markets ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... which will spark a conversation on the current obstacles facing infection prevention and ... completely preventable deaths caused by these infections. , The print component of ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... Digital Scientists, ... excited to announce the opening of a Greenville, South Carolina location. The ... digital progress in Greenville. , “We’ve been working with South Carolina clients for years ...
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study by NCPA Senior ... not obey the rules Congress has directed the CBO to follow. The CBO itself ... would restore. Yet, it estimates a reduction in employer-based coverage due to the GOP ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Texas , March 27, 2017   Genprex, Inc. , ... that Julien Pham , MD, the Company,s Chief Operating Officer, ... investor conferences. Sachs 5th Annual Cancer BioPartnering & ... New York, NY ... BioCentury 24th Annual Future Leaders in ...
(Date:3/24/2017)... , March 24, 2017 According to a new report ... and Industry Forecast, 2014-2022," the spine bone stimulators market was valued at $562 ... at a CAGR of 3.6% during the forecast period. ... ... Research Logo ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of the ... offering. ... the worldwide markets for Dental Implants in US$ Million. The report provides ... Japan , Europe , Asia-Pacific ... Annual estimates and forecasts are provided for the period ...
Breaking Medicine Technology: